Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eliotte E. Garling"'
Autor:
Salvatore Fiorenza, Olivier Humbert, Hans-Peter Kiem, Colin D. Godwin, Benjamin G. Hoffstrom, Roland B. Walter, Eliotte E. Garling, Tinh-Doan Phi, George S. Laszlo, Olivia M. Bates, Margaret C. Lunn, Cameron J. Turtle, Colin Correnti
Publikováno v:
Leukemia
There is increasing interest in targeting CD33 in malignant and non-malignant disorders. In acute myeloid leukemia, longer survival with the CD33 antibody-drug conjugate gemtuzumab ozogamicin (GO) validates this strategy. Still, GO benefits only some
Autor:
George S. Laszlo, Colin D. Godwin, Roland B. Walter, Eliotte E. Garling, Michael H. Cardone, Mary E. Beddoe, Sae Rin Jean, Olivia M. Bates
Publikováno v:
Leuk Lymphoma
Over 26,000 people will face a new diagnosis of acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) in 2020 in the U.S. alone, and only a minority will be long-term survivors [1]. Am...
Autor:
Mary E. Beddoe, Olivier Humbert, Colin D. Godwin, Margaret C. Lunn, Eliotte E. Garling, George S. Laszlo, Zhengwei J. Mao, Roland B. Walter, Hans-Peter Kiem, Brent L. Wood, Colin Correnti, Olivia M. Bates
Publikováno v:
Leukemia
Autor:
Mary E. Beddoe, Olivia M. Bates, Roland B. Walter, George S. Laszlo, Colin D. Godwin, Eliotte E. Garling
Publikováno v:
Br J Haematol
Autor:
Timothy J. Nice, Loralee Bandy, Eliotte E. Garling, Madeline J. Dinsdale, Leah C. S. Cepko, Joshua J. Faber-Hammond, Jay L. Mellies, William P. Scott
Publikováno v:
Journal of Medical Microbiology
PurposeTo identify therapeutic a bacteriophage that kills diarrheagenic enteroaggregativeEscherichia coli(EAEC) while leaving the human microbiome intact.MethodologyPhages from wastewater in Portland, OR, were screened for bacteriolytic activity usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5a694ae717062a246e93ae068f2217
https://doi.org/10.1101/385104
https://doi.org/10.1101/385104
Extensive evidence now implicates the acylated ghrelin peptide in the neural control of appetite and energy homeostasis. In addition to a stimulatory action on hypothalamic neurons controlling metabolic function, ghrelin acts on brain reward circuits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d51f18d9a88e8c844b257c232e5571c
https://doi.org/10.1016/b978-0-12-803750-8.00028-2
https://doi.org/10.1016/b978-0-12-803750-8.00028-2
While considerable work implicates the gastric peptide ghrelin in the neurohormonal control of appetite, more recent attention has focused on the peptide's role in the modulation of drug reward, including mechanisms mediating ethanol reinforcement. G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc1d7eeb13a6b98870c8659da3ad7828
https://doi.org/10.1016/b978-0-12-805373-7.00013-x
https://doi.org/10.1016/b978-0-12-805373-7.00013-x
Autor:
Eliotte E. Garling, Michael H. Cardone, Roland B. Walter, Mary E. Beddoe, Sae Rin Jean, Colin D. Godwin, Olivia M. Bates, George S. Laszlo
Publikováno v:
Blood. 134:2561-2561
BACKGROUND: With gemtuzumab ozogamicin (GO; targeting CD33) and inotuzumab ozogamicin (IO; targeting CD22), 2 antibody-drug conjugates delivering a toxic calicheamicin (CLM) derivative have recently been approved for the treatment of people with acut